Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000278367 represents a predicted or uncharacterized non-coding RNA transcript that is transcribed antisense to the protein-coding PROCR gene. Antisense transcripts are often involved in regulatory processes such as modulation of gene expression, RNA stability, or splicing of their sense counterparts, but for ENSG00000278367 there are no published functional studies or established roles in health or disease. Its biological significance, molecular function, and possible effects (if any) on PROCR or associated pathways remain undetermined. ENSG00000278367 "novel transcript, antisense to PROCR" is a non-coding RNA, not a canonical therapeutic target, and has no established function, biomarker use, or associated drugs. Its entry in drug target databases likely reflects gene annotation without proven biological or medical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to PROCR.